Navigation Links
BioSpecifics Announces Positive XIAPEX® Data Presented at XVI Annual Federation of European Societies for Surgery of the Hand Congress
Date:6/1/2011

ad not been previously operated experienced a decrease in fixed flexion contracture of 80 +/- 2.0%.(1) These results suggest that because repeat surgery is associated with a higher rate of complications as compared to initial surgery, XIAPEX may offer a promising alternative to patients who have had recurrence of Dupuytren's contracture following surgery.

There were two additional presentations discussing data on XIAPEX at the May 2011 FESSH Congress, as follows.

  • In a 9-month, open-label study in which 137 Dupuytren's contracture patients with primary flexion deformities of 20-100 degrees for MP joints or 20-80 degrees for proximal interphalangeal [PIP] joints received less than or equal to 3 CCH (0.58 mg) injections/cord (less than or equal to 5 injections/patient) at 30-day intervals, data were reported from patients enrolled at 12 sites in Denmark, Finland, Sweden, Switzerland and the United Kingdom. The primary endpoint was clinical success, defined as a reduction in contracture to less than or equal to 5 degrees 30 days after the last injection. The safety profile in this subgroup of patients was similar to that observed in previous studies. Long-term follow-up data are not yet available.(2)

  • In tissue explant cultures treated with XIAPEX, enzymatic digestion was most rapid in the first four hours following injection, with nearly complete lysis of collagen occurring within 12 hours. Collagen lysis in these in vitro experiments was confined to the area and volume of the injection, with sharp demarcation between the affected and adjacent unaffected areas. The result in these in vitro experiments appears to be selective lysis of the structural collagen components of the Dupuytren's cord with sparing of arteries, nerves and capillaries following local injection.(3)

About Collagenase

Collagenase is an enzyme that breaks down collagen
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioSpecifics Technologies Corp. Provides Update on XIAPEX® Launch Progress in EU
2. BioSpecifics Technologies Corp. to Present at SEVEN, Noble Financial Capital Markets Seventh Annual Equity Conference
3. BioSpecifics Technologies Corp. Announces Launch of XIAPEX® by Pfizer for Treatment of Dupuytrens Contracture in Europe
4. BioSpecifics Technologies Corp. to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference
5. BioSpecifics Technologies Corp. Amends Its Rights Agreement
6. BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
7. BioSpecifics Technologies Corp. Awarded Two Qualifying Therapeutic Discovery Project Grants
8. BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry Conference
9. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
10. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010
11. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... HAMBURG, Germany , Aug. 21, 2014 /PRNewswire/ ... collaborating with Deutsches Elektronen-Synchrotron ( DESY ), a leading ... to speed up management and storage of massive volumes ... Analytics architecture based on IBM software defined technology ... data at peak performance and help scientists worldwide gain ...
(Date:8/21/2014)... -- ACI Clinical ( www.aciclinical.com ) announces a new, ... Using this solution, trial sponsors can save ... and receive the same expertise that has made ... Leveraging a decade of DMC experience (initial ... programming and meeting facilitation), ACI analyzed DMC member ...
(Date:8/21/2014)... WOONSOCKET, R.I. , Aug. 21, 2014 CVS ... early tender results, applicable Reference Yields and consideration payable in ... Offers") commenced on August 7, 2014 for (1) any and ... and All Notes") and (2) up to a maximum amount ... due 2041 and 5.750% Senior Notes due 2017 (collectively, the ...
Breaking Medicine Technology:DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6
(Date:8/21/2014)... Dallas, TX (PRWEB) August 21, 2014 ... August 20 entertained residents with dementia at Silverado Turtle ... Improv Troupe, which consists of entertainers ranging from ages ... each time they perform their 40-minute set. The troupe's ... makes it universal and allows them to touch audiences ...
(Date:8/21/2014)... low or very low birth weight may be at ... findings, which appear in Diabetes Care , may ... diabetes in African American populations, which has a high ... University,s Slone Epidemiology Center followed more than 21,000 women ... course of 16 years, analyzing characteristics such as birth ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Not only is eating better ... them hundreds of health-care dollars a year, a new study ... of public health sciences at Wake Forest Baptist Medical Center ... obese type 2 diabetes patients. Participants ranged ... to either an intensive "lifestyle change program" focused on diet ...
(Date:8/21/2014)... Thompson HealthDay Reporter ... of therapy and antidepressants appears to best help people ... Four out of five people suffering from severe ... when treated with cognitive therapy plus antidepressant medication, researchers ... work much better than drugs alone in helping people ...
(Date:8/21/2014)... 21, 2014 A new study published ... increase in disability associated with speech problems from 2001-02 ... than 15% increase in disability associated with hearing problems. ... rising numbers of children who are experiencing communication disorders, ... , On a broader level, the new study, ...
Breaking Medicine News(10 mins):Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3
... some, addiction grabs hold quickly , , MONDAY, Oct. 1 (HealthDay ... drag a teen into smoking addiction, a new study suggests. ... tried smoking said their first cigarette brought them a feeling ... to become smokers. , "This provides further support for the ...
... first study to assess the stability of three aspects ... an increased risk of mortality in short sleep, long ... study published in the October 1 issue of the ... MD, PhD, of the Finnish Institute of Occupational Health ...
... (miRNA), better known for its roles in cancer, could ... HIV, the AIDS virus, evades detection, hiding in the ... have shown that when an individual infected with HIV ... (highly active antiretroviral therapy), the virus calls on miRNAs ...
... have identified a heart protection mechanism in mice that ... improve treatments for patients in future. , The research, ... Critical Care Medicine, was funded by the British Heart ... Physiology at the University of Bristol, and his colleagues ...
... saving lives, experts say , SUNDAY, Sept. 30 (HealthDay ... emergency care system responses to ensure that stroke patients ... So concludes a new policy statement from the American ... reduce the risk of death and disability in stroke ...
... FORT LAUDERDALE, Fla., Sept. 29 The North ... true magnitude of its,experience and commitment to Broward ... a name which truly reflects its,mission. The North ... The collective strength of its talented network of ...
Cached Medicine News:Health News:First Puff Can Turn Kids Into Smokers: Study 2Health News:First Puff Can Turn Kids Into Smokers: Study 3Health News:First Puff Can Turn Kids Into Smokers: Study 4Health News:Both short and long sleep is associated with increased mortality 2Health News:MicroRNAs may be key to HIV's ability to hide, evade drugs, Jefferson scientists find 2Health News:New research suggests hearts are experts at self-preservation 2Health News:Communities Can Speed Stroke Care 2Health News:Broward Health: New Name Draws on Collective Strength of Experience 2
... Comfort fit large designer ... adjustable strap bridge providing a ... on the nose. The head ... for custom fit. The acrylic ...
... Constructed of optical steel base metal with ... provides enhanced durability. Includes adjustable non-slip silicon ... Metalite comes with custom fitted lead sheet ... the front lenses for increased scatter radiation ...
All New Ultra Pb Series Glasses...
... Stylish and comfortable eye protection Properly ... 90% of scatter radiation. Our high quality ... and comfort with minimized weight. Our lenses ... optics that meet all industry standards. Most ...
Medicine Products: